Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA site-wide notice explains that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check32 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6), reflecting an update to the record's version history.SummaryDifference0.1%

- Check81 days agoChange DetectedNew Revision: v3.6.6 was added to the study record history and Revision: v3.6.5 was removed, updating the revision log to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.